fractiousrabbit
Greenlighter
- Joined
- Aug 22, 2015
- Messages
- 10
https://www.sciencedaily.com/releases/2016/03/160330135726.htm?trendmd-shared=1
I was reading the above article and the following stood out:
"Approval for a matchstick-sized implant called Probuphine that would release buprenorphine in a steady dose over six months was postponed by the Food and Drug Administration (FDA). An advisory committee recommended FDA approval in January, citing the benefits of reducing the burden of a medication regimen. Those against it say it could also put people at greater risk by reducing the patient doctor connection. "
I find the action typical of the FDA regarding certain drug classes, and diappointing. How can someone find out which organizations or individuals lobbied against the advisory panel to approve it? I really would be interested in knowing.
The complaint that it puts people at risk by reducing the number of office visits seems especially disingenuous to me. The few doctors I have talked to about suboxone, and one was my own PCP who is certified to prescribe it are not as knowledgeable as they should be and have some strange opinions about this medication. Most stated they believe people want to get on it to sell for other drugs and they also are of the belief it's almost as euphoric than say oxy variations. I told him he should ask his patients where they would rank it in terms of euphoria as my patients would not prefer any high they get from bupe over the usual fare by any stretch.
Decreasing the number of office visits would allow these docs to treat more patients and the fact that it is implanted would alleviate the fears that its being diverted. At every turn it looks like the people in charge of these decisions are just stacking the deck more and more against getting people help. Anything that doesn't sufficiently penialize or marginalize opioid users just won't do and has no place on their planet of perfect people.
Has anyone else heard about this implant coming to the US?
I was reading the above article and the following stood out:
"Approval for a matchstick-sized implant called Probuphine that would release buprenorphine in a steady dose over six months was postponed by the Food and Drug Administration (FDA). An advisory committee recommended FDA approval in January, citing the benefits of reducing the burden of a medication regimen. Those against it say it could also put people at greater risk by reducing the patient doctor connection. "
I find the action typical of the FDA regarding certain drug classes, and diappointing. How can someone find out which organizations or individuals lobbied against the advisory panel to approve it? I really would be interested in knowing.
The complaint that it puts people at risk by reducing the number of office visits seems especially disingenuous to me. The few doctors I have talked to about suboxone, and one was my own PCP who is certified to prescribe it are not as knowledgeable as they should be and have some strange opinions about this medication. Most stated they believe people want to get on it to sell for other drugs and they also are of the belief it's almost as euphoric than say oxy variations. I told him he should ask his patients where they would rank it in terms of euphoria as my patients would not prefer any high they get from bupe over the usual fare by any stretch.
Decreasing the number of office visits would allow these docs to treat more patients and the fact that it is implanted would alleviate the fears that its being diverted. At every turn it looks like the people in charge of these decisions are just stacking the deck more and more against getting people help. Anything that doesn't sufficiently penialize or marginalize opioid users just won't do and has no place on their planet of perfect people.
Has anyone else heard about this implant coming to the US?
